FWM
SRTA

Focused Wealth Management’s Strata Critical Medical Inc SRTA Stock Holding History

Focused Wealth Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,261
Closed -$102K – 1033
2023
Q3 		$102K Sell
39,261
-575
-1% -$2.02K 0.02% 195
2023
Q2 		$157K Sell
39,836
-400
-1% -$1.27K 0.03% 159
2023
Q1 		$136K Sell
40,236
-20,405
-34% -$83.2K 0.03% 171
2022
Q4 		$217K Sell
60,641
-2,125
-3% -$9.08K 0.04% 130
2022
Q3 		$253K Sell
62,766
-625
-1% -$3.21K 0.05% 110
2022
Q2 		$283K Hold
63,391
– – 0.05% 112
2022
Q1 		$538K Sell
63,391
-829
-1% -$5.83K 0.09% 88
2021
Q4 		$567K Sell
64,220
-1,803
-3% -$17.1K 0.09% 87
2021
Q3 		$687K Sell
66,023
-19,805
-23% -$173K 0.11% 78
2021
Q2 		$901K Buy
85,828
+3,765
+5% +$37.2K 0.15% 69
2021
Q1 		$844K Buy
82,063
+57,055
+228% +$794K 0.15% 74
2020
Q4 		$277K Buy
+25,008
New +$255K 0.05% 127

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Focused Wealth Management's SRTA Position: Q4 2023 in Review

Focused Wealth Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2023, closing a stake of 39,261 shares — an estimated $102K sold.

Focused Wealth Management first reported a position in SRTA in Q4 2020 and held it in 12 quarters. The position peaked at $901K in Q2 2021. 102 funds tracked by Wall St. Rank hold SRTA as of Q4 2023.

  • Focused Wealth Management reported no remaining Strata Critical Medical Inc position as of Q4 2023 after selling out during the quarter.
  • Focused Wealth Management sold 39,261 Strata Critical Medical Inc shares in Q4 2023, an estimated $102K.
  • Focused Wealth Management first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 12 quarters.
  • Focused Wealth Management's Strata Critical Medical Inc position peaked at $901K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2023.

Based on Focused Wealth Management's 13F filing for Q4 2023, filed 10 Jan 2024.